Literature DB >> 25482566

Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex.

Nancy F Ramia1, Michael Spilman1, Li Tang1, Yaming Shao1, Joshua Elmore2, Caryn Hale2, Alexis Cocozaki1, Nilakshee Bhattacharya1, Rebecca M Terns2, Michael P Terns3, Hong Li4, Scott M Stagg5.   

Abstract

The Cmr complex is the multisubunit effector complex of the type III-B clustered regularly interspaced short palindromic repeats (CRISPR)-Cas immune system. The Cmr complex recognizes a target RNA through base pairing with the integral CRISPR RNA (crRNA) and cleaves the target at multiple regularly spaced locations within the complementary region. To understand the molecular basis of the function of this complex, we have assembled information from electron microscopic and X-ray crystallographic structural studies and mutagenesis of a complete Pyrococcus furiosus Cmr complex. Our findings reveal that four helically packed Cmr4 subunits, which make up the backbone of the Cmr complex, act as a platform to support crRNA binding and target RNA cleavage. Interestingly, we found a hook-like structural feature associated with Cmr4 that is likely the site of target RNA binding and cleavage. Our results also elucidate analogies in the mechanisms of crRNA and target molecule binding by the distinct Cmr type III-A and Cascade type I-E complexes.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25482566      PMCID: PMC4269474          DOI: 10.1016/j.celrep.2014.11.007

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  36 in total

1.  EMAN: semiautomated software for high-resolution single-particle reconstructions.

Authors:  S J Ludtke; P R Baldwin; W Chiu
Journal:  J Struct Biol       Date:  1999-12-01       Impact factor: 2.867

2.  Automated molecular microscopy: the new Leginon system.

Authors:  Christian Suloway; James Pulokas; Denis Fellmann; Anchi Cheng; Francisco Guerra; Joel Quispe; Scott Stagg; Clinton S Potter; Bridget Carragher
Journal:  J Struct Biol       Date:  2005-07       Impact factor: 2.867

3.  Ab initio resolution measurement for single particle structures.

Authors:  Duncan Sousa; Nikolaus Grigorieff
Journal:  J Struct Biol       Date:  2006-08-15       Impact factor: 2.867

Review 4.  Evolution and classification of the CRISPR-Cas systems.

Authors:  Kira S Makarova; Daniel H Haft; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Yuri I Wolf; Alexander F Yakunin; John van der Oost; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2011-05-09       Impact factor: 60.633

5.  Reconstruction of helical filaments and tubes.

Authors:  Edward H Egelman
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

Review 6.  Small self-cleaving ribozymes.

Authors:  Adrian R Ferré-D'Amaré; William G Scott
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-15       Impact factor: 10.005

Review 7.  Catalysis by the nucleolytic ribozymes.

Authors:  David M J Lilley
Journal:  Biochem Soc Trans       Date:  2011-04       Impact factor: 5.407

8.  RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex.

Authors:  Caryn R Hale; Peng Zhao; Sara Olson; Michael O Duff; Brenton R Graveley; Lance Wells; Rebecca M Terns; Michael P Terns
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

9.  Small CRISPR RNAs guide antiviral defense in prokaryotes.

Authors:  Stan J J Brouns; Matthijs M Jore; Magnus Lundgren; Edze R Westra; Rik J H Slijkhuis; Ambrosius P L Snijders; Mark J Dickman; Kira S Makarova; Eugene V Koonin; John van der Oost
Journal:  Science       Date:  2008-08-15       Impact factor: 47.728

10.  Structure of the CRISPR interference complex CSM reveals key similarities with cascade.

Authors:  Christophe Rouillon; Min Zhou; Jing Zhang; Argyris Politis; Victoria Beilsten-Edmands; Giuseppe Cannone; Shirley Graham; Carol V Robinson; Laura Spagnolo; Malcolm F White
Journal:  Mol Cell       Date:  2013-10-10       Impact factor: 17.970

View more
  27 in total

1.  Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.

Authors:  Lilan You; Jun Ma; Jiuyu Wang; Daria Artamonova; Min Wang; Liang Liu; Hua Xiang; Konstantin Severinov; Xinzheng Zhang; Yanli Wang
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

Review 2.  Structure Principles of CRISPR-Cas Surveillance and Effector Complexes.

Authors:  Tsz Kin Martin Tsui; Hong Li
Journal:  Annu Rev Biophys       Date:  2015-05-27       Impact factor: 12.981

3.  Target sequence requirements of a type III-B CRISPR-Cas immune system.

Authors:  Kaitlin Johnson; Brian A Learn; Michael A Estrella; Scott Bailey
Journal:  J Biol Chem       Date:  2019-05-19       Impact factor: 5.157

4.  Cmr3 regulates the suppression on cyclic oligoadenylate synthesis by tag complementarity in a Type III-B CRISPR-Cas system.

Authors:  Tong Guo; Fan Zheng; Zhifeng Zeng; Yang Yang; Qi Li; Qunxin She; Wenyuan Han
Journal:  RNA Biol       Date:  2019-07-17       Impact factor: 4.652

5.  Structural Principles of CRISPR RNA Processing.

Authors:  Hong Li
Journal:  Structure       Date:  2014-11-26       Impact factor: 5.006

6.  Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity.

Authors:  Wenyan Jiang; Poulami Samai; Luciano A Marraffini
Journal:  Cell       Date:  2016-02-04       Impact factor: 41.582

Review 7.  A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses.

Authors:  Ryan N Jackson; Blake Wiedenheft
Journal:  Mol Cell       Date:  2015-05-28       Impact factor: 17.970

Review 8.  An updated evolutionary classification of CRISPR-Cas systems.

Authors:  Kira S Makarova; Yuri I Wolf; Omer S Alkhnbashi; Fabrizio Costa; Shiraz A Shah; Sita J Saunders; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Daniel H Haft; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Rebecca M Terns; Michael P Terns; Malcolm F White; Alexander F Yakunin; Roger A Garrett; John van der Oost; Rolf Backofen; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2015-09-28       Impact factor: 60.633

Review 9.  CRISPR-Based Technologies: Impact of RNA-Targeting Systems.

Authors:  Michael P Terns
Journal:  Mol Cell       Date:  2018-11-01       Impact factor: 17.970

10.  The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems.

Authors:  Kawanda Foster; Joshua Kalter; Walter Woodside; Rebecca M Terns; Michael P Terns
Journal:  RNA Biol       Date:  2018-08-01       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.